PRGO:NYE-Perrigo Company PLC (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 25.46

Change

-0.77 (-2.94)%

Market Cap

N/A

Volume

1.50M

Analyst Target

USD 57.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-0.96 (-0.49%)

USD 88.29B
HLN Haleon plc

+0.11 (+1.04%)

USD 48.57B
TAK Takeda Pharmaceutical Co Ltd A..

+0.06 (+0.42%)

USD 45.08B
RDY Dr. Reddy’s Laboratories Ltd..

+0.20 (+0.25%)

USD 13.46B
CTLT Catalent Inc

-0.34 (-0.56%)

USD 10.91B
ELAN Elanco Animal Health

-0.19 (-1.29%)

USD 7.26B
BHC Bausch Health Companies Inc

+0.11 (+1.35%)

USD 3.04B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.38 (+4.57%)

USD 2.69B
CPHI China Pharma Holdings Inc

-0.01 (-5.63%)

USD 3.66M
YCBD cbdMD Inc

-0.02 (-4.28%)

USD 1.73M

ETFs Containing PRGO

FLWR:SW 15.27 % 0.00 %

N/A

N/A
HLIT:CA Global X Lithium Producer.. 10.39 % 0.00 %

-0.22 (1.14%)

CAD 0.03B
ION Proshares S&P Global Core.. 3.98 % 0.00 %

+0.34 (+1.14%)

USD 2.24M
SDIP:LSE Global X SuperDividend UC.. 1.21 % 0.00 %

+0.05 (+1.14%)

USD 0.15B
SDIU:LSE Global X SuperDividend UC.. 1.21 % 0.00 %

+0.01 (+1.14%)

USD 0.26M
WSRD:CA Wealthsimple Developed Ma.. 1.10 % 0.00 %

-0.38 (1.14%)

CAD 0.70B
GNRX 0.00 % 0.55 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+0.03 (+1.14%)

N/A
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

+0.04 (+1.14%)

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
QDVM:F 0.00 % 0.00 %

N/A

N/A
QDVM:XETRA 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.88% 20% F 9% A-
Dividend Return 1.72% 60% D- 33% F
Total Return -19.17% 20% F 9% A-
Trailing 12 Months  
Capital Gain -17.31% 20% F 9% A-
Dividend Return 2.68% 80% B- 36% F
Total Return -14.63% 20% F 9% A-
Trailing 5 Years  
Capital Gain -52.13% 36% F 9% A-
Dividend Return 8.94% 50% F 29% F
Total Return -43.20% 43% F 9% A-
Average Annual (5 Year Horizon)  
Capital Gain -13.00% N/A N/A 5% F
Dividend Return -10.63% N/A N/A 6% D-
Total Return 2.37% N/A N/A 51% F
Risk Return Profile  
Volatility (Standard Deviation) 8.11% N/A N/A 82% B
Risk Adjusted Return -131.12% N/A N/A N/A F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector